前药
磷酰胺
药理学
口服
药代动力学
生物利用度
生物等效性
药品
医学
化学
立体化学
作者
Jinqian Liu,Wen Wang,Changqing Wang,Li Zhang,Xueliang Zhang,Shicong Liu,Yunhua Xu,Hailin Wang,Qing Dai,Chun Liu,Xinghai Wang,Zhengyu Yuan,M. F. GORDEEV
标识
DOI:10.1021/acsmedchemlett.2c00191
摘要
New oral antibiotic contezolid (CZD) is effective against Gram-positive infections but unsuitable for intravenous (IV) administration due to its modest solubility. To address the medical need for an IV form of CZD, its isoxazol-3-yl phosphoramidate derivatives have been explored, and contezolid acefosamil (CZA,
科研通智能强力驱动
Strongly Powered by AbleSci AI